Funding for this research was provided by:
National Cancer Institute (U54CA143906, P30CA014089)
Received: 5 March 2019
Accepted: 18 August 2019
First Online: 28 August 2019
Ethics approval and consent to participate
: The study was approved by the Institutional Review Board at the University of California San Diego (UP-14-00592). All patients consented to the study.
: Not applicable.
: The HD-SCA technology described here is licensed to Epic Sciences. LB, JH, JN, KB and PK have ownership in Epic Sciences. All other authors declare that they have no competing interests.